What type of study is this?

October 9, 2025Journal of Medical Genetics and Clinical Biology

Hematological and Biochemical Profiles in Rheumatoid Arthritis Patients Undergoing Methotrexate, Rituximab, and Combination Therapy

View Full Paper

Ask AI

Bookmark

Authors

AAAthraa Jaleel Al-ShemmaryUniversity of Alkafeel

Discussion

Member takes

Implication

Longitudinal assessment shows changes in biochemical and hematological markers in rheumatoid arthritis patients, highlighting potential kidney function complications.

Key Points

RA patients showed a significant decrease in hemoglobin levels during treatment, indicating a potential risk for anemia.
Platelet counts increased significantly in treated RA patients, contrasting with controls showing lower levels.
Kidney function declined as evidenced by increased creatinine and urea levels among RA patients under treatment.
ESR was significantly elevated in treated RA patients, suggesting heightened inflammatory activity compared to healthy controls.

Cite This Study

Athraa Jaleel Al-Shemmary (2025) studied this question.

synapsesocial.com/papers/68e7ba40ccde5f1021f64d42 https://doi.org/10.61796/jmgcb.v2i7.1354

View Full Paper

Ask AI

Bookmark

Implication

Longitudinal assessment shows changes in biochemical and hematological markers in rheumatoid arthritis patients, highlighting potential kidney function complications.

Hematological and Biochemical Profiles in Rheumatoid Arthritis Patients Undergoing Methotrexate, Rituximab, and Combination Therapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Hematological and Biochemical Profiles in Rheumatoid Arthritis Patients Undergoing Methotrexate, Rituximab, and Combination Therapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider